Shunqing Wang

12PUBLICATIONS
38CO-AUTHORS
Molecular targetsHaematological tumoursHaematologySocial epidemiologyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 05, 2026
Novel highly selective ROCK2 inhibitor (TDI01) for the treatment of chronic graft-versus-host disease: a multicenter, open-label phase Ib/II study.

|May 11, 2026
Somatic mutations in CSK disrupt immune regulation in a Chinese aplastic anemia cohort.

|Sep 15, 2025
Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia.

Liangliang Wu, Ming Zhou, Xiaowei Chen

|Aug 06, 2025
The endothelial activation and stress index as a risk factor for all-cause mortality in patients with anemia: a nationwide retrospective cross-sectional study.

Liangliang Wu, Gaiying Dong, Tingting Wu

|Jun 17, 2025
Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40-50: a retrospective analysis from the CBMTR over the past decade.

Xin Zhao, Yu-Ping Zhang, Bao-Dong Ye

|Feb 26, 2025
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD.

Yanmin M Zhao, Yi Luo, Jimin M Shi

Pageof 2

Frequent Collaborators

3 joint publications

Liangliang Wu

2 joint publications

Hai Yi

1 joint publications

Pei-Hua Lu

1 joint publications

Dai-Hong Liu